(newswire.net — January 24, 2013) Dunedin, FL – John Lux’s blog, www.investing-performance.com, has recommended American CryoStem Corporation (CRYO, OTCBB) as a long term buy.
CRYO’s principal line of business is the collection, processing and storage of adipose (fat) derived adult stem cells in order to permit individuals to preserve their stem cells and adipose tissue for potential future use in cell therapy and cosmetic and reconstructive surgery.
“We feel that CRYO is increasing its lead in commercializing adipose derived stem cells by developing a unique portfolio of patents and patent applications as well as a network of stem cell collection facilities by recruiting plastic surgeons,” said John Lux, blogger at www.investing-performance.com. “CRYO is working to create and market innovative patented cell culture medium products and tissue storage methods that support cosmetic and regenerative medicine applications that are being developed globally. American CryoStem is building the stem cell infrastructure that will be needed more and more in the future as regenerative medicine and cellular therapy progresses.”
Safe Harbor Statement
John Lux has a position in the restricted stock of the holding company of CRYO. See the website for more on this and other disclaimers. Information in this news release may contain statements about future expectations, plans, prospects or performance of American CryoStem Corporation that constitute forward-looking statements for purposes of the Safe Harbor Provisions under the Private Securities Litigation Reform Act of 1995. The words or phrases “can be”, “expects”, “may affect”, “believed”, “estimate”, “project” and similar words and phrases are intended to identify such forward-looking statements. You are cautioned that any forward-looking information provided by or on behalf of www.investing-performance.com is not a guarantee of future performance. This information is dependent upon important contingencies, of which there is no assurance. None of the information in this press release constitutes or is intended as an offer to sell securities or investment advice of any kind. CRYO’s actual results may differ materially from those anticipated in such forward-looking statements as a result of various important factors, some of which are beyond our control. All forward-looking statements are current only as of the date on which such statements were made. We do not undertake any obligation to publicly update any forward-looking statement to reflect events or circumstances after the date on which any such statement is made or to reflect the occurrence of unanticipated events.
Media Contact:
Heidi Gillion
Heidi@pr-publicrelations.info
Telephone: 323-250-9904